Health Care (CNBC)

Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn't have insurance coverage for the treatments.

Health Care (CNBC)

2 days 14 hours ago

Checkout news

Merck lowers profit outlook, partly due to $200 million expected tariff hit

Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump's planned pharmaceutical tariffs.

Health Care (CNBC)

3 days 13 hours ago

Checkout news

Why we're lowering our Bristol Myers price target despite an earnings beat, guidance raise

Shares of Bristol Myers Squibb fell modestly after the drugmaker's better-than-expected first-quarter results.

Health Care (CNBC)

3 days 15 hours ago

Checkout news

Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs

The guidance revisions include the estimated impact of current tariffs on U.S. products shipped to China, but not Trump's planned pharmaceutical tariffs.

Health Care (CNBC)

3 days 20 hours ago

Checkout news

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro.

Health Care (CNBC)

4 days 8 hours ago

Checkout news

FDA to phase out dyes used in Flamin' Hot Cheetos, Skittles and other snacks

The FDA is phasing out the use of petroleum-based synthetic dyes in food and drinks.

Health Care (CNBC)

5 days 11 hours ago

Checkout news

Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma

Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.

Health Care (CNBC)

5 days 14 hours ago

Checkout news

Danaher's quarterly results show signs of life, and the struggling stock soars

Count us among the Danaher investors breathing a sigh of relief.

Health Care (CNBC)

5 days 16 hours ago

Checkout news

Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro.

Health Care (CNBC)

6 days 14 hours ago

Checkout news

These are the 4 biggest things we're watching in the stock market in the week ahead

First-quarter earnings season picks up speed inside our portfolio and outside of it.

Health Care (CNBC)

1 week ago

Checkout news

UnitedHealth's stock is plunging on higher medical costs. That may mean trouble for more insurers

The warning sign from a health-care giant seen as the insurance industry's bellwether may mean trouble for companies with Medicare Advantage plans.

Health Care (CNBC)

1 week 3 days ago

Checkout news

Brain implant cleared by FDA for Precision Neuroscience, a Musk Neuralink rival

Precision Neuroscience announced that a core component of its brain implant system has been approved by the FDA.

Health Care (CNBC)

1 week 3 days ago

Checkout news

Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares jump 14%

The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming weight loss and diabetes market.

Health Care (CNBC)

1 week 3 days ago

Checkout news

Eli Lilly shares surge on new obesity pill data. What it means for the stock from here

Jim Cramer said Eli Lilly's new trial data has turned the obesity market into a 'one-horse race.'

Health Care (CNBC)

1 week 3 days ago

Checkout news

23andMe bankruptcy under congressional investigation for customer data

The House Committee on Energy and Commerce is investigating 23andMe's decision to file for bankruptcy

Health Care (CNBC)

1 week 3 days ago

Checkout news

Abbott Labs shares surge on earnings and a big sign of confidence in the business

Abbott's strong stock performance continued Wednesday after a first-quarter earnings beat and a guidance reaffirmation.

Health Care (CNBC)

1 week 4 days ago

Checkout news

Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs

What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its glucose monitoring system.

Health Care (CNBC)

1 week 4 days ago

Checkout news

Medical product manufacturers are divided over Trump's tariffs

Medical technology and device makers are fighting for tariff exemptions, while PPE makers are applauding the levies.

Health Care (CNBC)

1 week 4 days ago

Checkout news

CDC says measles cases are most likely underreported as outbreak swells in Texas

The leader of the CDC’s measles team said the agency was “scraping” to find resources to address an outbreak in the Southwest.

Health Care (CNBC)

1 week 4 days ago

Checkout news

Pfizer scraps daily weight loss pill after liver injury in one patient

The decision to stop developing danuglipron adds to a string of setbacks in the pharmaceutical giant's bid to win a slice of the booming market for GLP-1s.

Health Care (CNBC)

1 week 6 days ago

Checkout news